EXACT SCIENCES CORP's ticker is and the CUSIP is 30063PAC9. A total of 56 filers reported holding EXACT SCIENCES CORP in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,750,653 | -15.6% | 14,688,000 | 0.0% | 0.57% | -12.1% |
| Q2 2023 | $15,101,847 | -31.2% | 14,688,000 | -40.9% | 0.65% | -3.0% |
| Q1 2023 | $21,956,152 | +37.7% | 24,863,000 | +23.0% | 0.67% | +64.3% |
| Q4 2022 | $15,944,014 | -23.5% | 20,213,000 | -38.1% | 0.41% | -10.9% |
| Q3 2022 | $20,830,000 | -7.9% | 32,675,000 | 0.0% | 0.46% | -10.0% |
| Q2 2022 | $22,611,000 | -21.7% | 32,675,000 | 0.0% | 0.51% | -32.4% |
| Q1 2022 | $28,885,000 | +1.1% | 32,675,000 | +11.0% | 0.75% | +3.1% |
| Q4 2021 | $28,584,000 | +51.9% | 29,450,000 | +68.8% | 0.73% | +35.6% |
| Q3 2021 | $18,821,000 | -13.1% | 17,450,000 | 0.0% | 0.54% | -11.5% |
| Q2 2021 | $21,660,000 | +34.3% | 17,450,000 | +40.2% | 0.61% | +5.2% |
| Q1 2021 | $16,123,000 | -0.8% | 12,450,000 | 0.0% | 0.58% | +1.4% |
| Q4 2020 | $16,260,000 | -18.1% | 12,450,000 | -32.0% | 0.57% | -20.7% |
| Q3 2020 | $19,851,000 | +95.7% | 18,300,000 | +42.5% | 0.72% | +112.4% |
| Q1 2020 | $10,142,000 | – | 12,845,000 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARISTEIA CAPITAL, L.L.C. | 178,534,000 | $194,095,000 | 8.00% |
| LINDEN ADVISORS LP | 292,990,000 | $318,182,000 | 3.84% |
| CAMDEN ASSET MANAGEMENT L P /CA | 44,475,000 | $48,022,000 | 1.54% |
| Cheyne Capital Management (UK) LLP | 2,350,000 | $2,546,000 | 1.26% |
| DeepCurrents Investment Group LLC | 28,948,000 | $31,403,000 | 1.06% |
| Nicholas Investment Partners, LP | 6,965,000 | $7,521,000 | 0.81% |
| Lombard Odier Asset Management (Europe) Ltd | 11,518,000 | $12,499,000 | 0.74% |
| AQR Arbitrage LLC | 18,300,000 | $19,851,000 | 0.72% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 27,648,000 | $30,001,000 | 0.66% |
| BlueCrest Capital Management Ltd | 16,086,000 | $17,424,000 | 0.64% |